| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Wine, Eytan |
| dc.contributor.author | Aloi, Marina |
| dc.contributor.author | Van Biervliet, Stephanie |
| dc.contributor.author | Bronsky, Jiri |
| dc.contributor.author | Gasparetto, Marco |
| dc.contributor.author | Martín de Carpi, Javier |
| dc.contributor.author | Pellino, Gianluca |
| dc.date.accessioned | 2025-10-30T09:07:00Z |
| dc.date.available | 2025-10-30T09:07:00Z |
| dc.date.issued | 2025-09 |
| dc.identifier.citation | Wine E, Aloi M, Van Biervliet S, Bronsky J, di Carpi JM, Gasparetto M, et al. Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn’s and Colitis Organisation. J Pediatr Gastroenterol Nutr. 2025 Sep;81(3):765–815. |
| dc.identifier.issn | 1536-4801 |
| dc.identifier.uri | http://hdl.handle.net/11351/13973 |
| dc.description | Paediatric ulcerative colitis; Inflammatory bowel disease‐unclassified |
| dc.description.abstract | Objectives
Despite advances in the management of ambulatory paediatric ulcerative colitis (UC), challenges remain as many patients are refractory to therapy and some require colectomy. The aim of these guidelines is to provide an update on optimal care for UC through detailed recommendations and practice points.
Methods
These guidelines are an update to those published in 2018 and are a joint effort of the Paediatric IBD Porto group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation. An extensive literature search with subsequent evidence appraisal using the Oxford methodology was performed, followed by three online voting sessions and a consensus face-to-face meeting. Thirty-nine recommendations and 77 practice points were endorsed by the 25 experts with at least an 84% consensus rate.
Results
Robust evidence-based recommendations and detailed practice points are provided. In addition to reemphasising and updating the role of more ‘traditional’ UC therapies, these guidelines outline optimising the use of antitumour necrosis factor therapies and integrating newer biologics and small molecules, as well as supportive therapy, to improve outcomes and provide an updated management algorithm. Measurement and monitoring tools and decision aids are provided, and additional aspects, including nutritional support, extraintestinal manifestations, pouchitis, inflammatory bowel disease-unclassified and patient support, are discussed. Some aspects, including surgery and thromboprophylaxis, are covered in the acute severe UC guidelines.
Conclusions
These guidelines serve as an aid in managing children with UC through a combination of evidence-based recommendations and more practical practice points in the ambulatory setting. |
| dc.language.iso | eng |
| dc.publisher | Wiley |
| dc.relation.ispartofseries | Journal of Pediatric Gastroenterology and Nutrition;81(3) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Decisió, Presa de |
| dc.subject | Colitis ulcerosa - Tractament |
| dc.subject | Infants |
| dc.subject.mesh | Colitis, Ulcerative |
| dc.subject.mesh | /therapy |
| dc.subject.mesh | Consensus |
| dc.subject.mesh | Child |
| dc.title | Management of paediatric ulcerative colitis, part 1: Ambulatory care—An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn's and Colitis Organisation |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1002/jpn3.70097 |
| dc.subject.decs | colitis ulcerosa |
| dc.subject.decs | /terapia |
| dc.subject.decs | consenso |
| dc.subject.decs | niño |
| dc.relation.publishversion | https://doi.org/10.1002/jpn3.70097 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Wine E] Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada. University of Toronto, Toronto, Ontario, Canada. Department of Pediatrics, Division of Pediatric Gastroenterology, University of Alberta, Edmonton, Alberta, Canada. [Aloi M] Pediatric Gastroenterology, Hepatology and Cystic Fibrosis Unit, Department of Pathophysiology and Transplantation, University of Milan – Fondazione IRCCS Cà Granda – Ospedale Maggiore Policlinico di Milano, Milan, Italy. [Van Biervliet S] Pediatric Gastroenterology, Ghent University hospital, Ghent, Belgium. [Bronsky J] Department of Paediatrics, University Hospital Motol, Prague, Czech Republic. [Martín di Carpi J] Department of Pediatric Gastroenterology, Hepatology and Nutrition, Hospital Sant Joan de Déu, Barcelona, Spain. [Gasparetto M] Department of Paediatric Gastroenterology, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospitals, Faculty of Medicine and Health Science, University of East Anglia (UEA), Norwich, UK. [Pellino G] Unitat de Cirurgia de Còlon i Recte, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona UAB, Barcelona, Spain. Department of Advanced Medical and Surgical Sciences, Universitá degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy |
| dc.identifier.pmid | 40677018 |
| dc.identifier.wos | 001530564200001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |